Cargando…

LEARN algorithm: a novel option for predicting non-alcoholic steatohepatitis

BACKGROUND: There is an unmet need for accurate non-invasive methods to diagnose non-alcoholic steatohepatitis (NASH). Since impedance-based measurements of body composition are simple, repeatable and have a strong association with non-alcoholic fatty liver disease (NAFLD) severity, we aimed to deve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Gang, Zheng, Tian-Lei, Chi, Xiao-Ling, Zhu, Yong-Fen, Chen, Jin-Jun, Xu, Liang, Shi, Jun-Ping, Wang, Xiao-Dong, Zhao, Wei-Guo, Byrne, Christopher D., Targher, Giovanni, Rios, Rafael S., Huang, Ou-Yang, Tang, Liang-Jie, Zhang, Shi-Jin, Geng, Shi, Xiao, Huan-Ming, Chen, Sui-Dan, Zhang, Rui, Zheng, Ming-Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432286/ https://www.ncbi.nlm.nih.gov/pubmed/37600991 http://dx.doi.org/10.21037/hbsn-21-523

Ejemplares similares

Fully connected neural network-based serum surface-enhanced Raman spectroscopy accurately identifies non-alcoholic steatohepatitis
por: Gao, Feng, et al.
Publicado: (2022)

Higher consumption of animal organ meat is associated with a lower prevalence of nonalcoholic steatohepatitis
por: Zhang, Rui, et al.
Publicado: (2022)

Combined and sequential non-invasive approach to diagnosing non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease and persistently normal alanine aminotransferase levels
por: Zheng, Kenneth I, et al.
Publicado: (2020)

Non-alcoholic steatohepatitis and risk of hepatocellular carcinoma
por: Rios, Rafael S., et al.
Publicado: (2021)

Lipidomic identification of urinary extracellular vesicles for non-alcoholic steatohepatitis diagnosis
por: Zhu, Qingfu, et al.
Publicado: (2022)

Berberine ameliorates non-alcoholic steatohepatitis in ApoE(−/−) mice
por: Yang, Jin, et al.
Publicado: (2017)

Interaction of SAMM50-rs738491, PARVB-rs5764455 and PNPLA3-rs738409 Increases Susceptibility to Nonalcoholic Steatohepatitis
por: Xu, Ke, et al.
Publicado: (2022)

Non-invasive fibrosis assessment in non-alcoholic fatty liver disease
por: Rios, Rafael S., et al.
Publicado: (2020)

The role of Ursodeoxycholic acid in non-alcoholic steatohepatitis: a systematic review
por: Xiang, Zun, et al.
Publicado: (2013)

Characterization of High-Fat, Diet-Induced, Non-alcoholic Steatohepatitis with Fibrosis in Rats
por: Xu, Zheng-Jie, et al.
Publicado: (2009)

Research landscape and frontiers of non-alcoholic steatohepatitis-associated hepatocellular carcinoma: a bibliometric and visual analysis
por: Gao, Bowen, et al.
Publicado: (2023)

Hepatocyte apoptosis fragment product cytokeratin-18 M30 level and non-alcoholic steatohepatitis risk diagnosis: an international registry study
por: Zhang, Huai, et al.
Publicado: (2023)

PNPLA3 rs738409 C>G Variant Influences the Association Between Visceral Fat and Significant Fibrosis in Biopsy-proven Nonalcoholic Fatty Liver Disease
por: Li, Gang, et al.
Publicado: (2022)

Disease-specific miR-34a as diagnostic marker of non-alcoholic steatohepatitis in a Chinese population
por: Liu, Xiao-Lin, et al.
Publicado: (2016)

acNASH index to diagnose nonalcoholic steatohepatitis: a prospective derivation and global validation study
por: Wu, Xi-Xi, et al.
Publicado: (2021)

Lifestyle Interventions for Non-Obese Patients Both with, and at Risk, of Non-Alcoholic Fatty Liver Disease
por: Zhang, Xin-Lei, et al.
Publicado: (2022)

Old and new classes of glucose-lowering agents as treatments for non-alcoholic fatty liver disease: A narrative review
por: Miao, Lei, et al.
Publicado: (2022)

Deficiency of WTAP in hepatocytes induces lipoatrophy and non-alcoholic steatohepatitis (NASH)
por: Li, Xinzhi, et al.
Publicado: (2022)

Mechanisms of ductular reaction in non-alcoholic steatohepatitis
por: Chen, Yue, et al.
Publicado: (2022)

Jiang Zhi Granule protects immunological barrier of intestinal mucosa in rats with non-alcoholic steatohepatitis
por: Yu, Xiao, et al.
Publicado: (2021)

Assessing physician preferences on future therapeutic options and diagnostic practices in non-alcoholic steatohepatitis
por: Cook, Nigel, et al.
Publicado: (2020)

Extracts of Vine Tea Improve Diet-Induced Non-Alcoholic Steatohepatitis Through AMPK-LXRα Signaling
por: Chen, Yu-jun, et al.
Publicado: (2021)

Metformin Alleviates Steatohepatitis in Diet-Induced Obese Mice in a SIRT1-Dependent Way
por: Guo, Wan-rong, et al.
Publicado: (2021)

Assessing whether serum ceruloplasmin promotes non-alcoholic steatohepatitis via regulating iron metabolism
por: Xia, Ziqiang, et al.
Publicado: (2023)

Natural products that target macrophages in treating non-alcoholic steatohepatitis
por: Li, Chun-Lin, et al.
Publicado: (2020)

Radiomics based on fluoro-deoxyglucose positron emission tomography predicts liver fibrosis in biopsy-proven MAFLD: a pilot study
por: Chen, Zhong-Wei, et al.
Publicado: (2021)

A Pyridazinone Compound for Effectively Treating Non-alcoholic Steatohepatitis by Targeting THRβ
por: Cheng, Hao, et al.
Publicado: (2022)

Combined alcoholic and non-alcoholic steatohepatitis
por: Ntandja Wandji, Line Carolle, et al.
Publicado: (2020)

The Role of Epigenetic Changes in the Progression of Alcoholic Steatohepatitis
por: Kim, Hyeong Geug, et al.
Publicado: (2021)

P2X7 Receptor in Alcoholic Steatohepatitis and Alcoholic Liver Fibrosis
por: Xia, Guo-Qing, et al.
Publicado: (2022)

Oral Supplementation of Sodium Butyrate Attenuates the Progression of Non-Alcoholic Steatohepatitis
por: Baumann, Anja, et al.
Publicado: (2020)

Rotundic acid improves nonalcoholic steatohepatitis in mice by regulating glycolysis and the TLR4/AP1 signaling pathway
por: Shi, Xing-Yang, et al.
Publicado: (2023)

Experience with flap repair after vulvar carcinoma resection: a retrospective observational study of 26 cases
por: Zhang, Jiaqi, et al.
Publicado: (2022)

Individualized Polygenic Risk Score Identifies NASH in the Eastern Asia Region: A Derivation and Validation Study
por: Gao, Feng, et al.
Publicado: (2021)

Relationship of sarcopenia with steatohepatitis and advanced liver fibrosis in non-alcoholic fatty liver disease: a meta-analysis
por: Yu, Rui, et al.
Publicado: (2018)

Licorice extract inhibits the cGAS-STING pathway and protects against non-alcoholic steatohepatitis
por: Luo, Wei, et al.
Publicado: (2023)

Potential Blood DNA Methylation Biomarker Genes for Diagnosis of Liver Fibrosis in Patients With Biopsy-Proven Non-alcoholic Fatty Liver Disease
por: Sun, Qing-Feng, et al.
Publicado: (2022)

Fructose and Non-Alcoholic Steatohepatitis
por: Roeb, Elke, et al.
Publicado: (2021)

Statins in Non-alcoholic Steatohepatitis
por: Torres-Peña, Jose D., et al.
Publicado: (2021)

Role of Alcohol Metabolism in Non-Alcoholic Steatohepatitis
por: Baker, Susan S., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_n43jqd1ubb43juphpbdmpm67sh